Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas.
Condition(s):MacroprolactinomaLast Updated:June 14, 2010Unknown status
Hide Studies Not Open or Pending
Condition(s):MacroprolactinomaLast Updated:June 14, 2010Unknown status
Condition(s):Gestational Diabetes Mellitus in Pregnancy; Hyperprolactinemia PregnancyLast Updated:September 6, 2022Recruiting
Condition(s):Oral Lichen PlanusLast Updated:March 8, 2021Completed
Condition(s):Schizophrenia, Tardive Dyskinesia, Metabolic SyndromeLast Updated:May 2, 2007Unknown status
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:June 10, 2013Terminated
Condition(s):Pituitary Adenoma; Prolactinoma; Pituitary Tumor; Recurrence TumorLast Updated:March 18, 2020Recruiting
Condition(s):Thyroid CancerLast Updated:July 6, 2023Active, not recruiting
Condition(s):Hyperprolactinemia; Puberty Disorders; Metabolic Syndrome; Growth Disorders; Antipsychotics and Neuroleptics ToxicityLast Updated:July 25, 2023Recruiting
Condition(s):Acne VulgarisLast Updated:June 14, 2017Unknown status
Condition(s):Benign Breast Disease; Breast CancerLast Updated:November 25, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.